Staar Surgical Co(STAA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:10 PM ET (Korea 9/12 05:10)
Full metrics table
| Index | RUT | P/E | 340.75 | EPS (ttm) | 0.07 | Insider Own | 39.83% | Shs Outstand | 50.1M | Perf Week | -3.88% |
| Market Cap | 1.14B | Forward P/E | 41.94 | EPS next Y | 90.07% | Insider Trans | 3.47% | Shs Float | 30.2M | Perf Month | -10.82% |
| Enterprise Value | 0.99B | PEG | - | EPS next Q | 0.05 | Inst Own | 73.04% | Short Float | 14.13% | Perf Quarter | -21.59% |
| Income | 0.00B | P/S | 3.35 | EPS this Y | 128.43% | Inst Trans | -0.91% | Short Ratio | 4.84 | Perf Half Y | 23.22% |
| Sales | 0.34B | P/B | 3.11 | EPS next 5Y | - | ROA | 0.84% | Short Interest | 4.26M | Perf YTD | -1.86% |
| Book/sh | 7.29 | P/C | 6.26 | EPS past 3/5Y | - | ROE | 1.09% | 52W High | -36.83% ($35.87) | Perf Year | -19.3% |
| Cash/sh | 3.62 | P/FCF | - | Sales past 3/5Y | -5.57% 7.93% | ROIC | 0.97% | 52W Low | 45.4% ($15.59) | Perf 3Y | -49.2% |
| Dividend Est. | - | EV/EBITDA | 14 | EPS Y/Y TTM | 103.91% | Gross Margin | 74.76% | Volatility(W/M) | 4.57% 4.78% | Perf 5Y | -84.6% |
| Dividend TTM | - | EV/Sales | 2.92 | Sales Y/Y TTM | 51.3% | Oper. Margin | 18% | ATR (14) | 1.15 | Perf 10Y | 160.46% |
| Dividend Ex-Date | - | Quick Ratio | 4.03 | EPS Q/Q | 146.1% | Profit Margin | 1.13% | RSI (14) | 41.76 | Recom | 2.82 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.66 | Sales Q/Q | 111.04% | SMA20 | -3.51% ($23.48) | Beta | 1.17 | Target Price | $28.44 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 2026/8/12 | SMA50 | -8.06% ($24.65) | Rel Volume | 0.95 | Prev Close | $23.42 |
| Employees | 957 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | -27.73% 3.24% | SMA200 | -5.46% ($23.97) | Avg Volume(3M) | 0.88M | Price | $22.66 |
| IPO | 1983/7/7 | Option/Short | Yes/Yes | Trades | 11221 | Volume | 838,686 | Change | -3.25% |
Company
STAA is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
👁️ STAAR Surgical (STAA) is a U.S. ophthalmic medical device company that specializes in the development and manufacturing of Implantable Collamer Lenses (ICLs) for vision correction. Its flagship product, the EVO Visian ICL, corrects refractive errors such as myopia and astigmatism by inserting a lens into the eye rather than reshaping the cornea like LASIK or LASEK, and it has an extensive track record of cumulative implantations. The company has built a differentiated position in the high-myopia patient segment, where LASIK procedures are difficult to perform.
Over the past 1 year, roughly in the middle
37% below its 1-year high.
STAA makes money exceptionally well
18% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +128.4% this year.
Tap to view numbers
But it is not cheap
Trading at 340.8 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -49.2% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 73.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHE 0.02%
HULL 0.01%
PSCH 0.01%
SMIZ 0.00%
SQLV 0.00%It ranks #4 in the industry
Based on market cap of $1B.
STAA $1B PER 340.8
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is STAA?
STAA belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of STAA?
The market cap of STAA is approximately $1.1B, ranking 2,546 within its sector.
What is the P/E ratio of STAA?
STAA has a P/E ratio of approximately 340.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for STAA?
STAA has recorded a 52-week high of $35.87 and a low of $15.59.
